NP / PA
Pine Hollow Partner LLC
Pine Hollow Partner LLC was paid $7.06M by Medicaid between Jan 2018 and Dec 2024, across 22 billing codes. Its largest line is J0129, Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) — 78% of everything it billed.
33Billing provider infoPINE HOLLOW PARTNER LLC
EAST LANSING, MI 48823
EAST LANSING, MI 48823
33aNPI1275984700assigned 06/27/2016
33bProvider typeNurse Practitioner
28Total paid$7.06M
24GClaims18,112
24DCodes billed22
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Nurse Practitioner providers in Michigan
Rank by total paid#1 of 56
Median peer was paid$64K
This provider vs. median110×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 768 | $37K | |
| 2019 | 1,288 | $319K | |
| 2020 | 2,394 | $1.39M | |
| 2021 | 2,538 | $1.56M | |
| 2022 | 3,001 | $1.25M | |
| 2023 | 4,803 | $1.41M | |
| 2024incomplete | 3,320 | $1.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 78% | 1,591 | 1,447 | $5.50M |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 13% | 677 | 395 | $912K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.9% | 7,179 | 7,050 | $419K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 2,986 | 2,711 | $85K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.0% | 875 | 874 | $73K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 713 | 698 | $31K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,493 | 1,269 | $17K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 191 | 182 | $14K |
| 20610 | <1% | 104 | 78 | $3K | |
| 99443 | <1% | 30 | 30 | $2K | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 231 | 213 | $1K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 137 | 130 | $982.53 |
10 more codes
| 99441 | <1% | 35 | $870.11 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 448 | $823.77 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 83 | $488.53 |
| 96127 | <1% | 175 | $416.06 | |
| 90756 | <1% | 15 | $275.75 | |
| 90688 | <1% | 13 | $220.41 | |
| G0008 | Administration of influenza virus vaccine | <1% | 25 | $214.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15 | $97.65 |
| 1036F | 0% | 596 | $0.00 | |
| 4004F | 0% | 500 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZINK, IRIS (OWNER/AUTHORIZED OFFICIAL)